Insider Selling: RadNet Inc. (RDNT) EVP Sells 10,000 Shares of Stock
RadNet Inc. (NASDAQ:RDNT) EVP Norman R. Hames sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, March 16th. The stock was sold at an average price of $12.87, for a total transaction of $128,700.00. Following the sale, the executive vice president now owns 382,450 shares of the company’s stock, valued at $4,922,131.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
RadNet Inc. (NASDAQ RDNT) traded down $0.30 during trading on Friday, reaching $12.45. 766,360 shares of the company were exchanged, compared to its average volume of 299,443. RadNet Inc. has a 1 year low of $5.35 and a 1 year high of $13.40. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 7.88. The firm has a market cap of $607.21, a price-to-earnings ratio of -1,245,000.00, a price-to-earnings-growth ratio of 2.95 and a beta of 0.69.
RadNet (NASDAQ:RDNT) last posted its quarterly earnings data on Thursday, March 8th. The medical research company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). RadNet had a return on equity of 26.66% and a net margin of 0.01%. The firm had revenue of $235.50 million during the quarter, compared to analyst estimates of $228.46 million. During the same period in the prior year, the business posted $0.08 EPS. The company’s revenue for the quarter was up 4.7% on a year-over-year basis. equities analysts expect that RadNet Inc. will post 0.54 earnings per share for the current year.
A number of research firms recently commented on RDNT. FIX began coverage on shares of RadNet in a research note on Wednesday. They issued a “strong-buy” rating and a $15.00 price objective for the company. BidaskClub raised shares of RadNet from a “hold” rating to a “buy” rating in a research note on Wednesday. Jefferies Group set a $14.00 price objective on shares of RadNet and gave the stock a “buy” rating in a research note on Thursday, March 8th. Zacks Investment Research lowered shares of RadNet from a “buy” rating to a “hold” rating in a research note on Wednesday, January 10th. Finally, Raymond James Financial began coverage on shares of RadNet in a research note on Wednesday. They issued a “strong-buy” rating and a $15.00 price objective for the company. One equities research analyst has rated the stock with a hold rating, two have assigned a buy rating and two have given a strong buy rating to the company. RadNet has an average rating of “Buy” and an average price target of $13.75.
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.